Patents by Inventor Harry Quandt

Harry Quandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
    Publication number: 20210161994
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active octreotide at a constant rate for an extended period of time and methods of manufactures thereof. The device is very bio-compatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of octreotide to tissues or organs.
    Type: Application
    Filed: February 10, 2021
    Publication date: June 3, 2021
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
    Publication number: 20190365847
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active octreotide at a constant rate for an extended period of time and methods of manufactures thereof. The device is very bio-compatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of octreotide to tissues car organs.
    Type: Application
    Filed: June 28, 2019
    Publication date: December 5, 2019
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF RISPERIDONE AND METHODS OF USE THEREOF
    Publication number: 20160030337
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active risperidone at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of risperidone to tissues or organs.
    Type: Application
    Filed: June 10, 2015
    Publication date: February 4, 2016
    Applicant: BRAEBURN PHARMACEUTICALS BVBA SPRL
    Inventors: Petr Kuzma, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
    Publication number: 20150283201
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active octreotide at a constant rate for an extended period of time and methods of manufactures thereof. The device is very bio-compatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of octreotide to tissues or organs.
    Type: Application
    Filed: November 6, 2014
    Publication date: October 8, 2015
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • Implant device release agents and methods of using same
    Patent number: 9120249
    Abstract: Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more thereof. Hydrated implants may have a surface area of about 500 mm2 or greater.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: September 1, 2015
    Assignee: ENDO PHARMACEUTICALS SOLUTIONS INC.
    Inventors: Petr Kuzma, Stephanie Decker, Harry Quandt
  • Implantable device for the delivery of risperidone and methods of use thereof
    Patent number: 9078900
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active risperidone at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of risperidone to tissues or organs.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: July 14, 2015
    Assignee: BRAEBURN PHARMACEUTICALS BVBA SPRL
    Inventors: Petr Kuzma, Harry Quandt
  • Method of manufacturing an implantable device
    Patent number: 9072786
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: July 7, 2015
    Assignee: ENDO PHARMACEUTICALS SOLUTIONS INC.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • LONG TERM DRUG DELIVERY DEVICES WITH POLYURETHANE-BASED POLYMERS AND THEIR MANUFACTURE
    Publication number: 20150105746
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Application
    Filed: June 17, 2014
    Publication date: April 16, 2015
    Inventors: Petr Kuzma, Harry Quandt
  • Long term drug delivery devices with polyurethane-based polymers and their manufacture
    Patent number: 8784865
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: July 22, 2014
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • LONG TERM DRUG DELIVERY DEVICES WITH POLYURETHANE-BASED POLYMERS AND THEIR MANUFACTURE
    Publication number: 20140012222
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Application
    Filed: May 13, 2013
    Publication date: January 9, 2014
    Inventors: Petr Kuzma, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF HISTRELIN AND METHODS OF USE THEREOF
    Publication number: 20130302397
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active histrelin at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of histrelin to tissues or organs.
    Type: Application
    Filed: April 22, 2013
    Publication date: November 14, 2013
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • SUSTAINED DELIVERY OF EXENATIDE AND OTHER POLYPEPTIDES
    Publication number: 20130252894
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Method of manufacturing an implantable device
    Patent number: 8475820
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: July 2, 2013
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Long term drug delivery devices with polyurethane-based polymers and their manufacture
    Patent number: 8460274
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: June 11, 2013
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • Octreotide implant having a release agent
    Patent number: 8383577
    Abstract: Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: February 26, 2013
    Assignee: Endo Pharmaceuticals Solutions, Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Long term drug delivery devices with polyurethane-based polymers and their manufacture
    Patent number: 8303977
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: November 6, 2012
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Harry Quandt
  • LONG TERM DRUG DELIVERY DEVICES WITH POLYURETHANE-BASED POLYMERS AND THEIR MANUFACTURE
    Publication number: 20120231061
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 13, 2012
    Inventors: Petr KUZMA, Harry QUANDT
  • Implantable device for the sustained release of a polypeptide
    Patent number: 8071537
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: December 6, 2011
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
    Publication number: 20110244015
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active octreotide at a constant rate for an extended period of time and methods of manufactures thereof. The device is very bio-compatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of octreotide to tissues or organs.
    Type: Application
    Filed: September 29, 2009
    Publication date: October 6, 2011
    Inventors: Petr Kuzma, Harry Quandt
  • IMPLANTABLE DEVICE FOR THE DELIVERY OF HISTRELIN AND METHODS OF USE THEREOF
    Publication number: 20110236456
    Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active histrelin at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of histrelin to tissues or organs.
    Type: Application
    Filed: September 28, 2009
    Publication date: September 29, 2011
    Inventors: Petr Kuzma, Harry Quandt